Skip to main content
All lobbying clients

BIOGEN, INC.

Lobbying client · District of Columbia · filed 2025 to 2026

Biotechnology Company.

$8,820,000 Reported spend
32 Filings counted
4 Outside firms hired
12 Bills named

Spend is reported income plus in-house expenses across 32 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 5 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as BIOGEN, BIOGEN INC.

 Who filed for this client 5

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 12
  • H.R. 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    7 filings
  • S. 832
    EPIC Act of 2025
    7 filings
  • H.R. 946
    ORPHAN Cures Act
    4 filings
  • S. 864
    HELP Copays Act
    4 filings
  • H.R. 1262
    Mikaela Naylon Give Kids a Chance Act
    3 filings
  • H.R. 3747
    Accelerating Access to Dementia and Alzheimer’s Provider Training Act
    3 filings
  • H.R. 6130
    ASAP Act
    3 filings
  • S. 3267
    ASAP Act
    3 filings
  • H.R. 4317
    PBM Reform Act of 2025
    2 filings
  • H.R. 6837
    To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are con…
    2 filings
  • S. 3345
    PBM Price Transparency and Accountability Act
    2 filings
  • H.R. 1
    One Big Beautiful Bill Act
    1 filing
 Reported by year 2 years
  • 2026 $3,880,000 12 filings
  • 2025 $4,940,000 20 filings
 Issues lobbied 8

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 9
  • HOUSE OF REPRESENTATIVES 31
  • SENATE 31
  • Centers For Medicare and Medicaid Services (CMS) 13
  • Health & Human Services, Dept of (HHS) 10
  • White House Office 3
  • Treasury, Dept of 2
  • U.S. Trade Representative (USTR) 2
  • Executive Office of the President (EOP) 1
  • Veterans Affairs, Dept of (VA) 1
 Recent filings 33 total
Q3 report
FEDERAL STREET STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
DLA PIPER LLP (US)
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
BIOGEN
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $880,000 expenses · posted Oct 20, 2026
View →
Q3 report
TODD STRATEGY GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View →
Q2 report
FEDERAL STREET STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2 report
TODD STRATEGY GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2 report
BIOGEN
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $1,060,000 expenses · posted Jul 20, 2026
View →
Q2 report
DLA PIPER LLP (US)
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q1 report
FEDERAL STREET STRATEGIES, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 20, 2026
View →
Q1 report
BIOGEN
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $1,460,000 expenses · posted Apr 20, 2026
View →
Q1 report
TODD STRATEGY GROUP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 20, 2026
View →
Q4 termination amendment
JEFFREY J. KIMBELL & ASSOCIATES, INC.
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Apr 20, 2026
View →
Q1 report
DLA PIPER LLP (US)
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 20, 2026
View →
Q4 report
FEDERAL STREET STRATEGIES, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 20, 2026
View →
Q4 report
TODD STRATEGY GROUP
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 20, 2026
View →
Q4 report
DLA PIPER LLP (US)
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 20, 2026
View →
Q4 report
BIOGEN
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $770,000 expenses · posted Jan 19, 2026
View →
Q4 termination
JEFFREY J. KIMBELL & ASSOCIATES, INC. Amended
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 9, 2026
View →
Q3 report
FEDERAL STREET STRATEGIES, LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2025
View →
Q3 report
TODD STRATEGY GROUP
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2025
View →

Showing the 20 most recent of 33 filings. Search the explorer for "BIOGEN, INC.".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem